Medtronic's Guardian Connect continuous glucose monitoring system earned FDA approval March 12.
Here are four things to know.
1. The Guardian Connect system uses predictive analytics and artificial intelligence technology from IBM Watson Health to continually analyze glucose levels.
2. The system is the first smart continuous glucose monitoring system to alert patients of potential blood glucose events up to an hour ahead of time.
3. Guardian Connect can also pair to a smartphone, allowing users to track glucose levels in real-time and receive text alerts.
4. FDA approved the system for diabetes patients ages 14 to 75. Medtronic plans to launch Guardian Connect early this summer.